CASC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cascadian Therapeutics Inc's other income expense for the three months ended in Sep. 2016 was $0.02 Mil. Its other income expense for the trailing twelve months (TTM) ended in Sep. 2016 was $0.16 Mil.
Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.
Cascadian Therapeutics Inc Other Income (Expense) for the trailing twelve months (TTM) ended in Sep. 2016 was 0.02 (Dec. 2015 ) + 0.083 (Mar. 2016 ) + 0.042 (Jun. 2016 ) + 0.019 (Sep. 2016 ) = $0.16 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.
Cascadian Therapeutics Inc Annual Data
Cascadian Therapeutics Inc Quarterly Data